In search for objective measures of hyperactivity, impulsivity and inattention in adult attention deficit hyperactivity disorder using the Quantified Behavior Test Plus by Edebol, Hanna et al.
443 
 
Europe’s Journal of Psychology, 7(3), pp. 443-457 
www.ejop.org 
 
 
 
In search for objective measures of hyperactivity, impulsivity and 
inattention in adult attention deficit hyperactivity disorder using the 
Quantified Behavior Test Plus 
 
 
Hanna Edebol        Lars Helldin 
Karlstad University        NU health care 
 
Ebba Holmberg        Stig-Arne Gustafsson 
NU health care        NU health care 
 
          Torsten Norlander 
            Karlstad University 
 
 
Abstract 
Clinical assessment tools for adult attention deficit hyperactivity disorder (ADHD) such as 
rating scales, interviews and behavior observations are often based on subjective 
judgments which enhance the risk of overlooking or misinterpreting symptoms. In search 
for objective measures of adult ADHD, the present study investigated levels of sensitivity 
and specificity for the Quantified Behavior Test Plus, QbTest-Plus, in adult patients (N = 19) 
awaiting clinical assessment for ADHD. QbTest-Plus report objective measures of ADHD 
core symptoms using an infrared motion tracking system and a continuous performance 
test. The measures were collected and evaluated previous to clinical assessment and 
compared regarding the diagnosis of ADHD. Sensitivity for detecting ADHD with QbTest-
Plus was 83 % and specificity was 57 %. The results, possibly affected by confounding 
factors, suggest further examination of calibrated and objective measure for the QbTest-
Plus with regard to ADHD in adults. 
 
Keywords: attention deficit hyperactivity disorder, objective measures, clinical 
assessment, adults, the quantified behavior test plus. 
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Introduction 
 
The neurobiological developmental disorder Attention Deficit Hyperactivity Disorder 
(ADHD) occurs in about 2.5 percent of the adult population (Simon, Czobor, Bálint, 
Meszaros, & Bitter, 2009) and includes core symptoms of hyperactivity, impulsivity 
and inattention as described in the Diagnostic and Statistical Manual of Mental 
Disorders IV, DSM-IV (American Psychiatric Association, 2000). Past occurrence, 
current severity and the levels of malfunctioning that the symptoms impose on the 
patients´ everyday life are critical aspects of the diagnostic assessment (American 
Psychiatric Association, 2000).  
 
Assessment tools such as rating scales, clinical interviews and behavior observations 
are often based on subjective perception, second-hand information and the 
enhanced risk of overlooking or misinterpreting symptoms of adult ADHD which is 
reflected in unclear validity and weak inter-rater reliability (Gordon, Barkley, & Lovett, 
2006). There are few scientifically verified methodologies developed specifically for 
adults with ADHD but instead, the examiner will decide as to which 
neuropsychological tests to perform and how to interpret the results from the 
perspective of ADHD in adulthood and its differential diagnoses. Except for cognitive 
tests, objective and experimental measures of behavior symptoms may be 
performed. However, the few tests available for this purpose (Gordon, et al., 2006) 
have not been standardized satisfactorily for adults. Initially, the same 
neuropsychological procedures performed in childhood was adopted for ADHD in 
adulthood but over the years, a better understanding of developmental aspects as 
reflected in ceiling effects and low predictive values of psychometric tests have 
been supporting age-dependent and performance-based testing of the disorder.  
 
Also, diagnostic assessment of ADHD in adulthood is oftentimes complicated by 
comorbid psychiatric disorders, non-specific core diagnostic characteristics of ADHD 
and the prevalent diagnostic criterias that are developed with regard to symptom 
manifestations during childhood (Kaplan & Stevens, 2002). Studies of clinic-referred 
adults with ADHD report enhanced risks of developing lifelong comorbid 
psychopathology including for example mood, substance abuse, antisocial, 
conduct and eating disorders of which some are likely to be secondary to ADHD-
failure and frustration, which altogether makes objective assessment a complex and 
critical part of the clinical evaluation of ADHD in adulthood (Barkley, Fischer, 
Smallish, & Fletcher, 2002; Davidson, 2008; McGough et al., 2005; Murphy, Barkley, & 
Bush, 2002) 
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The continuous performance paradigm 
 
Objective measures of ADHD-core symptoms have been conducted with primary 
reference to children with the disorder, and less so with regard to the symptom 
manifestation in adults. Using for example Continuous Performance Tests (CPT) of 
cognitive core symptoms, e.g., inattention and impulsivity, children (Grodzinsky & 
Barkley, 1999; Teicher, Ito, Glod, & Barber, 1996) and adults (Ossman & Mulligan, 
2003; Weyandt, Mitzlaff, & Thomas, 2002) with ADHD tend to display higher rates of 
errors related to cognitive deficits, i.e., omission and commission errors, relative to 
clinical (Downey, Stetson, Pomerleau, & Giordani, 1997; Seidman, Biederman, 
Faraone, Weber, & Ouellette, 1997) and normative controls (Murphy, Barkley, & Bush, 
2001; Nigg et al., 2005). CPT measures also provide effective treatment monitoring of 
stimulants (Epstein et al., 2006; Konrad, Gunther, Hanisch, & Herpertz-Dahlman, 2004) 
and other treatment strategies (Klingberg, Forssberg, & Westerberg, 2002). However, 
a ceiling effect for adult subjects with ADHD has been suggested and especially 
when symptoms are less severe (Koelega, 1993), and there is a general lack of 
specificity with regard to clinical controls and cognitive symptom domains of adult 
ADHD (Epstein, Johnson, Varia, & Conners, 2001). 
 
Objective measures of hyperactivity 
 
For the motor domain of the disorder, i.e., hyperactivity, portable electronic activity 
monitors so called actigraphs and motion tracking systems (MTS) have been applied 
for detection of ADHD symptomathology in natural and laboratory settings of 
children, adolescents and to some extent also adults (Brocki, Tillman, & Bohlin, 2010; 
Halperin, Matier, Bedi, Sharma, & Newcorn, 1992; Halperin, Newcorn, Matier, Sharma, 
McKay, & Schwartz, 1993; Porrino, Rapoport, Behar, Sceery, Ismond, & Bunney, 1983). 
Successful monitoring of stimulant treatment effects (Vogt & Williams, 2011; Tabori-
Kraft, Sørensen, Dalsgaard, Kærgaard, & Thomsen, 2007), and associations between 
striatal dopamine markers and motor hyperactivity in male adolescents with ADHD 
has been reported (Jucaite, Fernell, Halldin, Forssberg, & Farde, 2005). Motor-signs in 
children with ADHD include 25-30 % higher activity levels, less complex but more 
linear movement patterns and especially during academic and laboratory-based 
tasks of attention as compared to healthy controls (Losier, McGrath, & Klein, 1996; 
Teicher, et al., 1996). Epidemiological findings of combined cognitive and motor 
symptoms in boys (Brocki et al., 2010) were positively correlated with age, suggesting 
that ADHD symptoms exists and varies along a continuum in the normal population. 
However, hyperactivity reflected in motor-activity is assumed to diminish with 
increased age (Brocki et al., 2010; Wilens, Biederman, & Spencer, 2002) but only 
three studies of objective measures of motor activity in adults with ADHD exist 
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(Boonstra, et al., 2007; Lis, Baer, Stein-en-Nosse, Gallhofer, Sammer, & Kirsch, 2010; 
Tuisku, et al., 2003), and they indicate measurable signs of increased motor activity in 
adult ADHD as compared to healthy participants. Age-relevant symptoms of 
hyperactivity are stipulated as diagnostic criteria in DSM-IV (American Psychiatric 
Association, 2004) and many adult subjects report fidgeting their feats and fingers 
several times a day (Murphy & Barkley, 1996). 
 
Combined measures of cognitive and motor domains in adult ADHD 
 
Recently, both cognitive and behavior domains of adult ADHD were measured using 
the Quantified Behavior Test Plus, QbTest-Plus (Lis et al., 2010). The test combines 
simultaneous objective measures of motor activity using infrared motion tracking 
systems and measures of attention and impulsivity using CPT measures. Core 
symptoms of ADHD were objectively measured in 20 adult subjects and separated 
from matched and healthy controls. Measures of hyperactivity were significant in the 
ADHD group using parameters such as distance, time active, area and micro-events. 
Hyperactivity offered higher separation than the cognitive parameters 
operationalized as omission and commission errors. The study suggests that 
hyperactivity was the core symptom that best separated ADHD from healthy 
controls and especially when measured in distance, i. e., the number of centimeters 
the subject has moved during the test. In the present study, we use these findings as 
a benchmark for assessment of the objective ADHD-measures, focusing on both 
motor and cognitive domains in attempts to optimize separation from ADHD and 
non-ADHD clinical subjects. We applied the combined measurement technique in a 
naturalistic sample of adult clinic-referred psychiatric patients in order to assess 
differential validity, i.e., sensitivity and specificity, for the Quantified Behavior Test Plus 
with regard to adult ADHD. 
 
Aim of the study 
 
The aim of the study is to investigate levels of sensitivity and specificity for the QbTest-
Plus with regard to ADHD in nineteen clinic-referred adult patients awaiting clinical 
assessment of ADHD. 
 
Quantities of hyperactivity, impulsivity and inattention are expected to be high in 
adults receiving a diagnosis of ADHD so that the core symptom triad will be sufficient 
for identifying a majority of the subjects with ADHD and separating them from a 
majority of the non-ADHD subjects. 
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Method 
 
Participants 
 
This study included 19 participants, 10 women and 9 men, who underwent clinical 
assessment for ADHD at the psychiatric clinic in the NU-health care. The participants 
mean age was 31.7 (SD = 9.3, range = 20 to 54). One person had not begun high 
school but a majority had completed (n = 6) or made parts of it (n = 9) and some (n 
= 3) had studied at post-graduate levels. Nine were singles, six either married or 
sharing household with a partner, three had a relationship and one person was 
divorced. A majority were unemployed, on sick-leave or carried sickness pension (n 
= 14) and the remaining part had full- or part-time work (n = 1), arranged daytime 
activities (n = 1), studied (n = 1), were on parents leave (n = 1) or retired (n = 1). The 
mean Body Mass Index was 26.2 (SD = 5.2, range = 18 to 35), and eleven persons 
regularly smoked tobacco while eight did not smoke at all. 
 
Participants were out-patients whose mean age for initial psychiatric contact was 
20.2 (SD = 10.9, N =12) and ten persons had undertaken psychiatric hospitalization 
one or more times starting at the mean age of 27.1 (SD = 9.9 range = 14 to 48). The 
mean of the latest Global Assessment of Functioning, GAF (Luborsky, 1962), which is 
a commonly used, qualitatively assessed and global measure of adult social, 
occupational, and psychological functioning ranging from 0 (severe dysfunction) to 
100 (perfect function) regarding both the level of symptom severity, which was 49.9 
(SD = 6.9, range = 40 to 60) and the level of adaptive functioning, which was 48.2 (SD 
= 8.8, range = 35 to 60) for participants of the present study, which indicate both 
serious symptoms and dysfunctions. Previous to clinical assessment of ADHD, all but 
two participants had at least one psychiatric diagnose and some (n = 8) had two. A 
total of seven participants had relapsing episodes of depression or dysthymia, five 
had various anxiety disorders or mixed states of anxiety and depression, three had a 
bipolar disorder, three had a substance abuse disorder, two had a personality 
disorders, one had an adaptive disorder and another participant had a diagnose of 
acute stress reaction at the time of the assessment. 
 
None had undergone clinical assessments for ADHD in childhood and a majority (n = 
14) had no family or relative with ADHD. Regarding medical treatment, 14 
participants generally used it but during the day of the study, participants used none 
(n = 8), one (n = 4), two (n = 5) or three and more (n = 2) medical treatments.  The 
following medical treatments were used by participants: antidepressants (n = 12), 
anxiolytics (n = 5), and neuroleptics (n = 3). The mean time from smoking or chewing 
tobacco at the first minute of the QbTest-Plus (see the instruments section) was 23.8 
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minutes (N = 11, SD = 14.7). Statistical analyses (Independent Samples t-test, 5 % 
level) did not reveal any significant differences between men and women with 
regard to age, BMI, education, age at first contact with psychiatry, GAF-symptom, 
GAF-function, or ASRS (see the instrument section). 
 
Design 
 
The current study evaluated levels of sensitivity and specificity for the QbTest-Plus 
with regard to ADHD using objective measures of ADHD core symptoms. The 
independent variable was the clinical assessment regarding the diagnosis of ADHD. 
The dependent variable was the results of the QbTest-Plus, which was collected and 
analyzed prior to the clinical assessment. Clinical assessments were made by trained 
clinicians in the NU-health care and typically included observations, childhood 
anamnesis, self-report symptom scales, information from relatives, psychological or 
occupational-therapeutic tests and sometimes additional batteries of well-chosen 
psychological tests performed by specialists in neuropsychiatry. The psychiatric 
center asserted the DSM-IV (American Psychiatric Association, 2000) for diagnostic 
considerations. DSM-IV includes three subtypes of ADHD that was categorized into 
one dichotomous variable of No (not ADHD) or Yes (ADHD is established) and 
compared with the outcome of QbTest-plus; “Probably not ADHD”, “Possibly ADHD, 
further assessment is needed” or “Probably ADHD”. 
 
Instruments 
 
QbTest-plus. This instrument (Knagenhjelm & Ulberstad, 2010) combines a Continuous 
Performance Test (CPT) installed as a software program on a PC with measures of 
attention and impulsivity and an activity test with measures of motor-activity during 
20 minutes. While performing the CPT-test on the computer, movements of the 
participant are recorded using an infrared camera following a reflective marker 
attached to a head-band. The CPT-test involves rapid presentations of figures with 
various shapes (square or circle) and colors (red or blue) and the participant are 
instructed to press a handheld button when a stimuli subsequently repeats itself (a 
target) and not to press the button when the stimulus varies relative to the previous 
one (a non-target). The stimuli are presented at a pace of one per two seconds, 
each one visible for 200 milliseconds, and the total number of stimuli is 600, presented 
with a 25 % target probability. 
 
QbTest-Plus aims to provide objective information regarding core-symptoms of 
ADHD; hyperactivity on basis of motor-activity measured with the camera, and 
inattention and impulsivity on basis of the CPT-test. In this study, hyperactivity has 
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been operationalized with the parameter called "distance", i.e., the length of the 
path describing the movement of the headband reflector during the test. 
Inattention is operationalized on basis of omission errors (no response is registered 
and the stimulus was a target) and impulsivity with commission errors (a response is 
registered and the stimulus was a non-target). Cut-off levels (Q-score 1.3) of core-
items are based on 149 male and 118 female (N = 267) healthy controls from thirteen 
to fifty-five years of age and is set at the 90th percentile of the distribution 
(Knagenhjelm et al., 2010). For means and standard deviations of the present study 
see Table 1. 
 
Table 1: The results of hyperactivity, impulsivity and inattention using QbTest-Plus 
 
QbTest-Plus 
Core Item 
M SD Min Max 
Hyperactivity 5.86 4.47 2.00 16.80 
Impulsivity 3.30 8.29 0.00 37.10 
Inattention 14.04 13.81 0.00 54.00 
 
The results of hyperactivity, impulsivity and inattention using QbTest-Plus. Means (M), 
Standard Deviations (SD), Minimum (Min), and Maximum (Max) scores of the QbTest-
Plus core items; hyperactivity (distance), impulsivity (commission errors), and 
inattention (omission errors). 
 
Procedure 
 
Nurses informed patients awaiting clinical assessment about the purpose and 
procedure of the study and the interested patients were registered for participation. 
When arriving at the psychiatric centre, the participant was met by a researcher and 
the written informed consent obtained. Instructions for the QbTest-Plus were given 
both verbally and by means of the standardized video presenting procedures of the 
test (Knagenhjelm, et al, 2010). Participants performed a one minute pre-test to 
ensure instructions had been understood correctly. After QbTest-plus was performed, 
the participant answered questions about demographics and current medication. 
The psychiatric record and the status of the assessment were unknown throughout 
the process of experimental testing and assessment. Results would not intervene with 
clinical assessment. Methods and results of the clinical assessments, the GAF, 
medical treatment, psychiatric anamnesis and clinical diagnosis were collected. The 
study procedures were examined and approved by the Regional Ethical Review 
Board of Uppsala, Sweden (2008/110/2). 
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Analysis of data 
 
Objective core items from QbTest; hyperactivity measured in distance, impulsivity 
measured with commission errors and inattention measured with omission errors, 
were divided into either "No” or "Yes” relative to the predetermined cut-off level 
indicating moderately atypical behavior (Q-score > 1.3) (Knagenhjelm et al., 2010). 
Core items were combined into a total judgment of either "Probably not ADHD” (all 
three No), "Possibly ADHD, further assessment is needed” (one or two Yes) or 
"Probably ADHD” (all three Yes) which were compared with the independent 
variable of "No” or "Yes” regarding the clinical diagnosis of ADHD. 
 
Results 
 
Sensitivity for detecting ADHD was 83 % and specificity was 57 %. Comparisons 
between clinical assessments and the QbTest-Plus indicated 74 % accuracy 
including ten true positive and four true negative cases, as well as three false positive 
and two false negative cases. The positive predictive value was 77 % and the 
negative predictive value was 66 %. 
 
Discussion 
 
The present study investigated levels of sensitivity and specificity for QbTest-Plus 
regarding ADHD in 19 adult patients awaiting clinical assessment for ADHD. Sensitivity 
for detecting ADHD was 83 % and the specificity was 57 % when compared to the 
clinical assessment. As expected, objective measures of the core symptom triad 
were sufficient for identifying a majority of the subjects with ADHD. As expected, the 
core symptoms were also sufficient for extracting a majority of the subjects without 
ADHD. However, the level of specificity was just a little better than chance and the 
present study therefore tentatively suggest that the test is unsuitable for disconfirming 
a diagnosis of ADHD. The test performance may be triggered by other reasons than 
ADHD. All participants qualified for an ADHD-assessment but had substantial 
psychiatric disorders with ADHD-core symptoms per se, which may influence levels of 
sensitivity in clinical samples. One asset of the objective behavioural measures is that 
core symptoms are recorded and presented regardless of the hypothetical reasons. 
But in order to interpret and apply the measures during diagnostic assessment for 
example; clinicians will be able to consider other clinical data and use QbTest-Plus 
according to the complementary intents of the test. 
 
  
 Europe’s Journal of Psychology 
 
 
451
Psychiatric comorbidity is common for adults undertaking clinical screens and 
assessment for ADHD (Kaplan, et al., 2002). A majority of the clinically recruited 
participants of the current study had comorbid psychiatric disorders which 
hypothetically influences the levels of sensitivity and specificity. The QbTest-Plus are 
not intended to disentangle multifaceted comorbidity but rather to measure and 
quantify adult ADHD as one of other integrated facets of a clinical procedure. 
Having a blind design of the current study did not allow preparations based on the 
clinical records. Prospective studies would preferably have as much of diagnostically 
pure groups as possible in order to investigate levels of sensitivity and specificity with 
regard to ADHD in adult participants. 
 
Using rather small samples, Epstein et al (2001) compared adult participants with 
ADHD (N = 25), participants with anxiety symptomatology (N = 15), and healthy 
participants (N = 30) by means of Conners´ CPT (Conners, 1992; Conners, 1995). 
Significantly higher rates of commission errors were found for the ADHD versus both 
other groups but non-significant rates of commission errors for participants with 
anxiety versus the healthy participants. Other studies of continuous performance 
tests and adult ADHD have found similar results for commission errors (Cohen and 
Shapiro, 2007), omission errors (Johnson, Epstein, Waid, Latham, Voronin, & Anton, 
2001), and response speed (Himelstein & Halperin, 2000; Johnson, et al., 2001), but 
the samples were rather small. Seidman and colleagues (1998) reported differences 
between healthy controls, adults with ADHD and adults with schizophrenia by means 
of omission and commission errors. Adults with ADHD made fewer errors than clinical 
controls but more errors than normative controls. For most part, CPT studies of adults 
with ADHD are limited by the fact that small sample sizes and assorted CPT 
paradigms are applied for testing which limits the statistical power to detect effect 
sizes. In general, results from previous CPT studies suggest that measures of ADHD 
core symptoms may hold significant discriminative value when comparing groups 
with ADHD and healthy controls but that psychiatric comorbidity may seriously limit 
the discriminative power. Discriminative power of combined CPT and MTS measures 
was investigated by Lis and collegues (2010) who reported most discriminative 
power for objective measures of motor activity for participants with ADHD and 
healthy controls. 
 
Today there are no golden standards available for assessing test-statistics of the 
QbTest-Plus. In order to assess data from participants, the current study utilized cut-
off scores based on the 90th percentile of the normative dataset (see the instruments 
section) and previous studies of predictive measures of ADHD core symptoms in 
children and adults (Brocki et al., 2010; Lis et al., 2010). Other alternatives for 
identifying cut-off scores, such as roc-curve analysis were not helpful. A calibrated 
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and composite measure based on continuous scores for the whole ADHD core 
symptom spectra would perhaps facilitate the objective of QbTest-Plus with regard 
to adult patients. 
 
Limitations 
 
The present study had some limitations. The participants had comorbid psychiatric 
disorders with joint symptoms vis-à-vis ADHD. Among others this included bipolar, 
anxiety, mood and personality disorders. Twelve participants used one or more 
psychotropic medications and the current study did not make apparent whether 
the sample was representative for clinic-referred adults suspected to have ADHD in 
general. The results may therefore be regarded tentatively. Hopefully, future studies 
will be able to investigate psychometric properties of the test thoroughly. 
 
Conclusions 
 
The present study reported 83 % sensitivity and 57 % specificity for the QbTest-Plus 
with regard to adult ADHD. The results, possibly affected by confounding factors, 
may be regarded tentatively and suggest further examination of calibrated and 
objective measures from the test. Future research may investigate behavioral 
measures with regard to adult clinical and healthy controls, as well as compare the 
results with other assessment tools of ADHD in adulthood. The current study was one 
of the first to investigate objective behavioral measures of the core symptom triad in 
adult ADHD, and a majority of participants with ADHD was possible to identify. The 
study is limited but encourages further research on behavioral measures of 
hyperactivity, impulsivity and inattention in adult ADHD. 
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